undamentalytics Newsletter
Sign in

Carecloud, Inc. (CCLD) stock

Add to watchlist

Add holding +

NASDAQ: CCLD Nasdaq Health Care Technology Next results ~November 5, 2026

B+ Fundamentals grade

Carecloud, Inc. is a US-listed company in the health care technology industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: our cash-flow value ($11.25) was left out of our combined valuation (it is 6.72x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating.

Price vs value

Under review: our cash-flow value ($11.25) was left out of our combined valuation (it is 6.72x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating. We'll show the comparison once resolved.

Carecloud, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 1 selling0 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds31 adding, 38 cuttingOf 19 active managers that changed their stake, 5 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Carecloud files

Where Carecloud stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $129m, up 15.1% on a year earlier, faster than the 10.3% growth a quarter earlier. Free-cash-flow margin fell to 17.7% from 19.5% a year earlier. Operating margin narrowed to 7.1% from 10.5%. The diluted share count is up 73.1% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades B+. It passes 1 of our 2 financial-health checks.

Our model value for Carecloud is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Carecloud, Inc.'s trailing-twelve-month revenue grew 15.1% year on year, with a free-cash-flow margin of 17.7%. Where it stands out: stock pay as % of revenue of 0.3% ranks 1 of 22 health care technology companies we cover. Where it lags: change in share count of 73.1% ranks 17 of 19 health care technology companies we cover.

Our discounted-cash-flow model values the business at ~$11 per share in the base case (~$8.5–$15 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 4.8% while net income fell 29.1%: a 34pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 15.1% over the last 12 months, against a median of 8.8% for health care technology companies we cover.
  • Growth speeding up. The growth rate is 4.7 points higher than a quarter earlier.

Things to watch

  • Results due soon. Results are expected around 5 November; the share price can move sharply on the day.
  • Margins narrowing. Operating margin is down 3.4 points on a year ago.
  • Share dilution. Diluted shares rose 73.1% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 62% and a beta of 0.9 against the S&P 500.
  • Missing expectations. Earnings per share fell short of the consensus estimate in 2 of the last four quarters.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$0.06 against an average estimate of $0.06: missed by 5.3%
Revenue
$32m, up 16.4% on a year earlier
Share reaction
+3.5% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Guidance given
revenue $128m to $132m (Full Year 2026); adjusted EBITDA $29m to $31m (Full Year 2026)
Next report
November 5, 2026; average EPS estimate $0.12

Carecloud's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-2.3%
  • 1 week+0.6%
  • 1 month-14.9%
  • This year-41.1%
  • 1 year-41.7%
  • 5 years-79.3%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$129M
Operating margin
7.1%
Net margin
6.2%
EPS (TTM, diluted)
$0.19

Growth

Revenue growth
+15.1%
Change in growth rate
+4.7 pts
Share count change
+73.1%

Cash

Free cash flow (TTM)
$22.8M
FCF margin
17.7%
Stock pay % of revenue
0.3%

Earnings

Last results
August 6, 2026
Next results (est.)
November 5, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Results
  3. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Carecloud, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: our cash-flow value ($11.25) was left out of our combined valuation (it is 6.72x the share price, outside the 0.2-5x range we accept), so it can't be the basis of a rating.

Our value per share comes from a discounted-cash-flow model of Carecloud, Inc.'s free cash flow after stock-based pay ( $20.5M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Carecloud, Inc. as an operating company, with every model that fits that kind of business. Cost of equity 10.4%: the 10-year Treasury yield (4.9%) plus a beta of 1.22 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$11 ~$8.5–$15 Left out: out of range vs price (6.54x)
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$2.0 ~$2.6–$3.1 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Carecloud, Inc. with Health Care Technology in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$1.20$0.72$2.61$3.80$4.06$9.07$6.32$2.81$1.52$3.66$2.92$1.72
Market value$12m$7m$29m$45m$49m$115m$92m$42m$24m$59m$111m$73m
+ Net debt (− = net cash)$1m$14m−$4m−$14m−$19m−$20m−$632000−$4m$0$0$0$0
Enterprise value$13m$21m$25m$31m$30m$95m$91m$39m$24m$59m$111m$73m
Multiples
Price / sales 0.5x0.3x0.9x0.9x0.8x1.1x0.7x0.3x0.2x0.5x0.9x0.6x
Price / earnings ——————32.4x7.8x—7.5x10.3x9.2x
Price / free cash flow ———7.7x8.8x—8.8x2.3x1.9x3.1x4.7x3.2x
EV / EBITDA 91.1x——98.2x9.7x58.1x5.8x2.1x—2.5x4.2x2.9x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

33 /100

Weak moat

How hard Carecloud's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -1.6% of total assets over 8 years.

  • Durability 10 / 20

    Operating margin has been a median -2.0%; its worst year was -38.7%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 8 of 10 years, at a median 10.8% of revenue.

  • Discipline 7 / 20

    The diluted share count rose 213.0% over five years; stock-based pay has been a median 4.6% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (38 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, before the open. Analysts expect revenue of $33m and EPS of $0.12 (range $0.07 to $0.16) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $0.36 +7% $130m +8%
Next $0.30 +91% $143m +10%

Next year's EPS estimate has moved +4.0% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.5% on 90 days ago. In the last 30 days, 1 analyst raised Carecloud, Inc.'s forecast and 0 cut it.

Consensus EPS forecast Carecloud, Inc., last 90 days
$0.28 $0.30 $0.32 $0.34 $0.36 $0.38 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $0.37 Current fiscal year, 60 days ago: $0.37 Current fiscal year, 30 days ago: $0.37 Current fiscal year, 7 days ago: $0.37 Current fiscal year, Now: $0.36 $0.36 Next fiscal year, 90 days ago: $0.29 Next fiscal year, 60 days ago: $0.29 Next fiscal year, 30 days ago: $0.30 Next fiscal year, 7 days ago: $0.30 Next fiscal year, Now: $0.30 $0.30

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $0.37$0.29
60 days ago $0.37$0.29
30 days ago $0.37$0.30
7 days ago $0.37$0.30
Now $0.36$0.30

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.06 $0.06 −5.3%
Mar 2026 $0.05 $0.05 +7.1%
Dec 2025 $0.11 $0.11 0.0%
Sept 2025 $0.08 $0.10 +25.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026
  • Revenue Full Year 2026 $128m to $132m Maintained
    “$ 128 - $132 million” source
  • Adjusted EBITDA Full Year 2026 $29m to $31m Non-GAAP Maintained
    “$ 29 - $31 million” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

How our valuation uses these forecasts

Our cash-flow model grows Carecloud, Inc.'s revenue by +6.5% next year and +8.3% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+6.2%, weight 33%) , management guidance (+5.9%, weight 40%) and the company's own record (+7.9%, weight 27%) . How the weights are set.

Analyst recommendations

2 analysts, Oct 2026
Buy2100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026112
  2. Sep 20261113

Counts of recommendations published by analysts covering Carecloud, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
1.8%
of tradable shares
Days to cover
2.88
at average volume
Short interest, 1 month
+8%
to October 15, 2026
Held by institutions
23%
of shares
Held by insiders
15.3%
of shares
Employees
3,650
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CCLD−30%−56%−46%+141%−20%−41%
Industry peers (median)−9%−67%−16%−24%−28%−26%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CCLD42%17%50%50%50%18%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CCLD−59%−60%−83%−53%−74%−55%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 94% from August 10, 2020 to December 14, 2023. Getting back needed a 1575% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.71 – $3.81
From 52-week high
−54.9%
vs 50-day average
−16.2%
vs 200-day average
−30.6%
Volatility (1 year)
62%
Beta vs S&P 500
0.87

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
8 up, 4 down
typical move ±9.8%
After a week
8 up, 4 down
typical move ±16.4%
After a month
8 up, 4 down
typical move ±18.8%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 +3.5% +0.5% −3.5% −12.2%
May 7, 2026 −21.1% +0.5% −28.4% −20.7%
March 12, 2026 +18.0% −2.1% +33.8% +5.3%
November 6, 2025 +17.5% −1.0% +7.8% +5.8%
August 5, 2025 +7.1% +0.3% +6.3% +47.1%
May 6, 2025 +7.4% −0.4% +13.1% +23.4%
March 13, 2025 −8.1% +0.7% −1.2% −25.6%
November 12, 2024 +0.4% −0.3% +7.3% +24.5%
August 13, 2024 +15.2% +2.0% +32.8% +29.4%
May 14, 2024 −3.9% +1.7% +26.7% +12.7%
March 21, 2024 −3.4% +0.1% −2.5% −5.9%
November 2, 2023 +12.6% +2.8% +33.3% +12.6%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Carecloud, Inc. in five measures

Fundamentals grade B+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Carecloud, Inc.
$110M $115M $120M $125M $130M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $121.2M Revenue (TTM), FY23 Q4: $117.1M Revenue (TTM), FY24 Q1: $113M Revenue (TTM), FY24 Q2: $111.7M Revenue (TTM), FY24 Q3: $111M Revenue (TTM), FY24 Q4: $110.8M Revenue (TTM), FY25 Q1: $112.5M Revenue (TTM), FY25 Q2: $111.8M Revenue (TTM), FY25 Q3: $114.3M Revenue (TTM), FY25 Q4: $120.5M Revenue (TTM), FY26 Q1: $124.1M Revenue (TTM), FY26 Q2: $128.6M $128.6M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $121.2M
FY23 Q4 $117.1M
FY24 Q1 $113M
FY24 Q2 $111.7M
FY24 Q3 $111M
FY24 Q4 $110.8M
FY25 Q1 $112.5M
FY25 Q2 $111.8M
FY25 Q3 $114.3M
FY25 Q4 $120.5M
FY26 Q1 $124.1M
FY26 Q2 $128.6M
Revenue growth, TTM YoY Carecloud, Inc.
-20% -10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -15.7% Revenue growth, TTM YoY, FY23 Q4: -15.7% Revenue growth, TTM YoY, FY24 Q1: -15.3% Revenue growth, TTM YoY, FY24 Q2: -11.0% Revenue growth, TTM YoY, FY24 Q3: -8.4% Revenue growth, TTM YoY, FY24 Q4: -5.3% Revenue growth, TTM YoY, FY25 Q1: -0.5% Revenue growth, TTM YoY, FY25 Q2: 0.0% Revenue growth, TTM YoY, FY25 Q3: 3.0% Revenue growth, TTM YoY, FY25 Q4: 8.7% Revenue growth, TTM YoY, FY26 Q1: 10.3% Revenue growth, TTM YoY, FY26 Q2: 15.1% 15.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -15.7%
FY23 Q4 -15.7%
FY24 Q1 -15.3%
FY24 Q2 -11.0%
FY24 Q3 -8.4%
FY24 Q4 -5.3%
FY25 Q1 -0.5%
FY25 Q2 0.0%
FY25 Q3 3.0%
FY25 Q4 8.7%
FY26 Q1 10.3%
FY26 Q2 15.1%
Operating margin (TTM) Carecloud, Inc.
-60% -40% -20% 0% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -2.1% Operating margin (TTM), FY23 Q4: -40.2% Operating margin (TTM), FY24 Q1: -41.4% Operating margin (TTM), FY24 Q2: -38.7% Operating margin (TTM), FY24 Q3: -34.2% Operating margin (TTM), FY24 Q4: 8.2% Operating margin (TTM), FY25 Q1: 9.8% Operating margin (TTM), FY25 Q2: 10.5% Operating margin (TTM), FY25 Q3: 10.2% Operating margin (TTM), FY25 Q4: 9.4% Operating margin (TTM), FY26 Q1: 8.3% Operating margin (TTM), FY26 Q2: 7.1% 7.1%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -2.1%
FY23 Q4 -40.2%
FY24 Q1 -41.4%
FY24 Q2 -38.7%
FY24 Q3 -34.2%
FY24 Q4 8.2%
FY25 Q1 9.8%
FY25 Q2 10.5%
FY25 Q3 10.2%
FY25 Q4 9.4%
FY26 Q1 8.3%
FY26 Q2 7.1%
FCF margin (TTM) Carecloud, Inc.
10% 15% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 12.1% FCF margin (TTM), FY23 Q4: 10.6% FCF margin (TTM), FY24 Q1: 14.1% FCF margin (TTM), FY24 Q2: 13.0% FCF margin (TTM), FY24 Q3: 16.2% FCF margin (TTM), FY24 Q4: 17.1% FCF margin (TTM), FY25 Q1: 17.5% FCF margin (TTM), FY25 Q2: 19.5% FCF margin (TTM), FY25 Q3: 18.8% FCF margin (TTM), FY25 Q4: 19.7% FCF margin (TTM), FY26 Q1: 18.1% FCF margin (TTM), FY26 Q2: 17.7% 17.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 12.1%
FY23 Q4 10.6%
FY24 Q1 14.1%
FY24 Q2 13.0%
FY24 Q3 16.2%
FY24 Q4 17.1%
FY25 Q1 17.5%
FY25 Q2 19.5%
FY25 Q3 18.8%
FY25 Q4 19.7%
FY26 Q1 18.1%
FY26 Q2 17.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Carecloud took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $120M
  2. Research and development $6.4M · 5.3%
  3. Selling, general and admin $23.2M · 19.3%
  4. Other operating costs $79.6M · 66.0%
  5. Operating income $11.3M · 9.4%
  6. Net income $10.8M · 9.0%

Shares of revenue. Source: Carecloud's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 10 18 23 24 32 51 64 105 140 139 117 111 120 129
EBITDA 1 −1 0 −3 −0 0 3 2 16 18 −33 23 26 25
Operating income −0 −4 −4 −8 −5 −3 0 −8 4 7 −47 9 11 9
Net income −0 −5 −5 −9 −6 −2 −1 −9 3 5 −49 8 11 8
Diluted EPS −$0.03 −$0.64 — −$0.95 −$0.69 −$0.59 −$0.60 −$1.79 −$0.77 −$0.67 −$4.11 −$0.28 $0.10 $0.19
Growth (year on year)
Revenue — +74.8% +26.1% +6.1% +29.9% +58.9% +27.5% +63.1% +32.8% −0.6% −15.7% −5.3% +8.7% +15.1%
EBITDA — −252.2% — — — — — −46.8% — +16.6% −278.4% — +13.1% +1.0%
Operating income — — — — — — — — — +87.3% −812.8% — +24.4% −21.7%
Net income — — — — — — — — — +91.5% −996.1% — +37.5% −29.1%
Diluted EPS — — — — — — — — — — — — — −59.0%
Margins
EBITDA margin 7.8% −6.8% 0.6% −11.4% −0.7% 0.6% 4.8% 1.6% 11.3% 13.2% −27.9% 21.0% 21.8% 19.6%
Operating margin −1.2% −22.1% −19.3% −32.3% −14.2% −5.0% 0.1% −7.9% 2.5% 4.8% −40.2% 8.2% 9.4% 7.1%
Net margin −1.7% −24.6% −20.3% −35.9% −17.5% −4.2% −1.4% −8.4% 2.0% 3.9% −41.6% 7.1% 9.0% 6.2%
Free-cash-flow margin 6.1% −20.9% −10.0% −5.5% −1.3% 11.4% 8.7% −3.3% 7.5% 13.4% 10.6% 17.1% 19.7% 17.7%
Cash flow
Cash from operations 1 −3 −2 −1 0 7 8 −1 13 21 15 21 29 27
Capital spending 0 1 0 0 1 1 2 3 3 3 3 2 5 4
Free cash flow 1 −4 −2 −1 −0 6 6 −3 10 19 12 19 24 23
Stock-based pay 0 0 1 2 1 2 3 7 5 5 5 0 0 0
Free cash flow after stock pay 1 −4 −3 −3 −2 3 2 −10 5 14 8 19 23 22
Balance sheet
Cash 0 1 8 3 4 14 20 21 9 12 — — — —
Total debt 3 2 9 17 0 1 1 1 9 9 11 1 2 9
Net debt (negative = net cash) 2 1 1 14 −4 −14 −19 −20 −1 −4 — — — —
Diluted shares 5m 7m 10m 10m 11m 12m 12m 13m 15m 15m 16m 16m 38m 43m
Returned to shareholders
Buybacks — 0 0 1 — — — — — — — — — —
Total returned — 0 0 1 — — — — — — — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 2 checks passed · June 30, 2026
What it owns · $94m
Short-term assets $34mLonger-term assets $60m
What it owes, and who funded it · $94m
Short-term liabilities $33mLonger-term liabilities $43mShareholders' equity $17m
  • Short-term assets cover short-term liabilities $34m of assets due within a year against $33m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $34m short-term assets against $43m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Carecloud, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+73.1%
year over year
R&D spending
6.8%
of revenue
Days sales outstanding
40 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care technology
Last 12 months unless stated CCLD OPRX SOPH AMWL DH HCAT Median
Revenue, last 12 months $129m $99m $77m $219m $233m $292m $292m
Revenue growth, last 12 months 15.1% −5.8% 18.6% −19.0% −5.0% −7.5% 8.8%
Revenue growth, 3-year average 0.8% 17.0% — −7.4% −0.8% 0.9% 0.8%
Revenue growth, latest quarter 16.4% −29.8% — −26.6% −9.1% −12.7% 7.4%
Gross margin — 73.2% 67.4% — 75.2% — 58.6%
Operating margin 7.1% 11.1% −91.8% −37.3% −104.6% −84.4% −12.5%
Operating margin, 3-year average −7.0% −6.8% — −72.7% −194.0% −48.1% −18.8%
Net margin 6.2% 4.7% −102.2% −35.7% −72.3% −90.6% −12.5%
Cash from operations / revenue 20.8% 18.7% −46.5% −12.1% 17.8% 9.7% 9.7%
Free-cash-flow margin 17.7% 18.6% −47.2% −12.1% 12.3% 9.2% 9.2%
Free-cash-flow margin, 3-year average 16.7% 8.7% — −34.5% 15.3% 1.7% 8.2%
Stock pay / revenue 0.3% 8.1% 21.0% 5.9% 10.9% 6.0% 9.5%
Change in share count 73.1% 2.5% 2.2% 6.2% −7.4% 10.3% 2.9%

Median of all 23 companies we cover in health care technology. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

23 health care technology companies
Measure Company Peer median Rank
Revenue growth Growth 15.1% 8.8% 9 of 23
Change in growth rate Growth +4.7pp -0.3pp 5 of 23
Operating margin Profitability 7.1% -6.6% 8 of 22
Net margin Profitability 6.2% -12.5% 6 of 23
Free-cash-flow margin Cash generation 17.7% 10.6% 7 of 22
Stock pay as % of revenue Cash generation 0.3% 9.7% 1 of 22
Long-term debt as % of assets Balance sheet 0.3% 20.1% 3 of 15
Change in share count Balance sheet 73.1% 2.6% 17 of 19
Days sales outstanding Balance sheet 40 days 58 days 6 of 21

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Healthcare IT $107M 88.4% ▲ 10.5%
Medical Practice Management $13.9M 11.6% ▼ 3.5%
Products and services
Line of business Revenue YoY
Chronic Care Management $2.8M ▼ 6.7%
Remote Patient Monitoring $794,000 ▲ 1.9%

These categories overlap or exclude eliminations, so shares aren't shown.

From Carecloud, Inc.'s 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$20.3M
Institutions reporting
65
Shares held vs prior quarter
▼ 19.3%
Positions opened / closed
8 / 17

Top buyers and sellers, Q2 2026: 31 institutions bought and 38 sold ; the biggest buyer was Globeflex Capital L P (+335K shares) and the biggest seller Essex Investment Management Co LLC (−698K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Vanguard Capital Management LLC $3.6M 1.7M 17.5% ▲ 14.1%
Hillsdale Investment Management Inc. $2M 923K 9.6% ▲ 14.8%
Two Sigma Investments, LP $1.2M 580K 6.1% ▲ 48.8%
Dimensional Fund Advisors LP $1.2M 576K 6.0% ▲ 52.5%
American Century Companies Inc $1.1M 510K 5.3% ▼ 31.1%
Ameriprise Financial Inc $936,300 442K 4.6% ▼ 35.4%
Geode Capital Management, LLC $894,140 422K 4.4% ▼ 4.6%
Bridgeway Capital Management, LLC $867,631 409K 4.3% ▼ 1.6%
Wells Fargo & Company $816,200 385K 4.0% ▲ 11.3%
Globeflex Capital L P $710,510 335K 3.5% New
Arrowstreet Capital, Limited Partnership $709,795 335K 3.5% ▲ 32.9%
Blackrock, Inc. $485,826 229K 2.4% ▲ 16.9%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Carecloud, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $51,150 1 trade by 1 insider · 0% under pre-set plans
Net ▼ $51,150 net selling
Insider Date Trade Shares Price Value
Daly John N Director November 10, 2025 Sell 15,000 $3.41 $51,150

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 7 trades and filings

No trades in Carecloud, Inc. disclosed in the last 12 months; 7 earlier trades on record.

  • Kevin Hern(R-OK 1):Sale (full), $1,001 - $15,000, traded December 8, 2023, filed January 13, 2024
  • Kevin Hern(R-OK 1):Sale (full), $1,001 - $15,000, traded December 19, 2022, filed January 13, 2023
  • Kevin Hern(R-OK 1):Sale (full), $1,001 - $15,000, traded May 16, 2022, filed June 14, 2022

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 5, 2026 estimated from the company's past filing pattern, not announced

  • August 6, 2026
  • May 7, 2026
  • March 12, 2026
  • November 6, 2025
  • August 5, 2025
  • May 6, 2025

Recent SEC filings

Data status

When each part of this page on Carecloud, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Carecloud, Inc. in brief

What does Carecloud, Inc. do?
Carecloud, Inc. is a US-listed company in the health care technology industry. Its financial year ends in December.
What is Carecloud, Inc.'s stock ticker?
Carecloud, Inc. trades under the ticker CCLD on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Carecloud, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Carecloud, Inc. reported revenue of $129M, 15.1% higher than a year earlier, according to its SEC filings.
What is Carecloud, Inc.'s free cash flow?
Carecloud, Inc.'s free-cash-flow margin is 17.7% of revenue over the trailing twelve months, ranking 7 of the 22 health care technology companies we cover.
Who are Carecloud, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Vanguard Capital Management LLC, Hillsdale Investment Management Inc. and Two Sigma Investments, LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Carecloud, Inc.'s market cap?
On November 2, 2026, Carecloud, Inc.'s market capitalisation was about $73.4M, with a price-to-earnings ratio of 9.2 and net debt of $0. Market figures come from third-party market data and may be delayed.
Who are Carecloud, Inc.'s competitors?
In our Health Care Technology peer group, the companies closest to Carecloud, Inc. are Optimizerx Corp, Sophia Genetics SA, American Well Corp, Definitive Healthcare Corp. and Health Catalyst, Inc. The side-by-side comparison below sets their revenue, margins and growth against Carecloud, Inc.'s.
Are insiders buying or selling Carecloud, Inc. stock?
Over the last 12 months, Carecloud, Inc.'s directors and officers reported 0 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is Carecloud, Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Carecloud, Inc. announces its own schedule.